We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Chimerix Inc | NASDAQ:CMRX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.012 | -1.23% | 0.963 | 0.95 | 0.98 | 1.02 | 0.96 | 0.9735 | 272,098 | 23:57:40 |
|
Delaware
|
| |
33-0903395
|
|
|
(State or other jurisdiction of incorporation or organization)
|
| |
(I.R.S. Employer Identification Number)
|
|
|
2505 Meridian Parkway, Suite 100
Durham, NC 27713 (919) 806-1074 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) |
|
|
Large accelerated filer ☐
|
| | Accelerated filer ☑ | |
|
Non-accelerated filer ☐ (Do not check if a smaller reporting company)
|
| | Smaller reporting company ☐ | |
| | | | Emerging growth company ☐ | |
| | ||||||||||||||||||
Title of each class of securities to be registered
|
| |
Amount to be
Registered |
| |
Proposed Maximum
Offering Price per Unit |
| |
Proposed Maximum
Aggregate Offering Price |
| |
Amount of
Registration Fee(1) |
| ||||||
Common Stock, par value $0.001 per share
|
| | | | (2 ) | | | | | | (3 ) | | | |
(3)
|
| |
—
|
|
Preferred Stock, par value $0.001 per share
|
| | | | (2 ) | | | | | | (3 ) | | | |
(3)
|
| |
—
|
|
Debt Securities
|
| | | | (2 ) | | | | | | (3 ) | | | |
(3)
|
| |
—
|
|
Warrants
|
| | | | (2 ) | | | | | | (3 ) | | | |
(3)
|
| |
—
|
|
Total
|
| | | | (2 ) | | | | | | | | | |
$250,000,000
|
| |
$31,125(4)
|
|
|
| | | | | ii | | | |
| | | | | 1 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 12 | | | |
| | | | | 19 | | | |
| | | | | 22 | | | |
| | | | | 26 | | | |
| | | | | 28 | | | |
| | | | | 28 | | | |
| | | | | 28 | | | |
| | | | | 29 | | |
| | |
Year Ended December 31,
|
| |
Nine Months
Ended September 30, |
| ||||||||||||||||||||||||||||||
| | |
2012
|
| |
2013
|
| |
2014
|
| |
2015
|
| |
2016
|
| |
2017
|
| ||||||||||||||||||
Ratio of earnings to fixed charges(1)(2)
|
| | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |
| | |
Page
|
| |||
| | | | ii | | | |
| | | | S-1 | | | |
| | | | S-2 | | | |
| | | | S-3 | | | |
| | | | S-5 | | | |
| | | | S-6 | | | |
| | | | S-7 | | | |
| | | | S-9 | | | |
| | | | S-12 | | | |
| | | | S-13 | | | |
| | | | S-13 | | | |
| | | | S-13 | | | |
| | | | S-14 | | |
|
Assumed public offering price per share
|
| | | | | | | | | $ | 5.07 | | |
|
Net tangible book value per share of as September 30, 2017
|
| | | $ | 5.03 | | | | | | | | |
|
Decrease in net tangible book value per share attributable to this offering
|
| | | $ | (0.03 ) | | | | | | | | |
|
As adjusted net tangible book value per share as of September 30, 2017, after giving effect to this offering
|
| | | | | | | | | $ | 5.00 | | |
|
Dilution per share to investors purchasing our common stock in this offering
|
| | | | | | | | | $ | 0.07 | | |
|
|
SEC registration fee
|
| | | $ | 31,125 | | |
|
Accounting fees and expenses
|
| | | | (1 ) | | |
|
Legal fees and expenses
|
| | | | (1 ) | | |
|
Transfer agent fees and expenses
|
| | | | (1 ) | | |
|
Trustee fees and expenses
|
| | | | (1 ) | | |
|
Printing and miscellaneous expenses
|
| | | | (1 ) | | |
|
Total
|
| | | $ | (1 ) | | |
|
|
Signatures
|
| |
Title
|
| |
Date
|
|
|
/s/ M. Michelle Berrey, M.D., M.P.H.
M. Michelle Berrey, M.D., M.P.H.
|
| |
President, Chief Executive Officer
and Director (Principal Executive Officer) |
| |
November 29, 2017
|
|
|
/s/ Timothy W. Trost
Timothy W. Trost
|
| |
Senior Vice President, Chief Financial Officer and Corporate Secretary
(Principal Financial and Accounting Officer) |
| |
November 29, 2017
|
|
|
/s/ Ernest Mario, Ph.D.*
Ernest Mario, Ph.D.
|
| |
Chairman of the Board of Directors
|
| |
November 29, 2017
|
|
|
/s/ James M. Daly*
James M. Daly
|
| |
Member of the Board of Directors
|
| |
November 29, 2017
|
|
|
/s/ Martha J. Demski*
Martha J. Demski
|
| |
Member of the Board of Directors
|
| |
November 29, 2017
|
|
|
/s/ Catherine Gilliss, Ph.D., R.N., FAAN*
Catherine Gilliss, Ph.D., R.N., FAAN
|
| |
Member of the Board of Directors
|
| |
November 29, 2017
|
|
|
/s/ John M. Leonard, M.D.*
John M. Leonard, M.D.
|
| |
Member of the Board of Directors
|
| |
November 29, 2017
|
|
|
Signatures
|
| |
Title
|
| |
Date
|
|
|
/s/ Patrick Machado*
Patrick Machado
|
| |
Member of the Board of Directors
|
| |
November 29, 2017
|
|
|
/s/ James Niedel, M.D., Ph.D.*
James Niedel, M.D., Ph.D.
|
| |
Member of the Board of Directors
|
| |
November 29, 2017
|
|
|
/s/ Ronald C. Renaud, Jr.*
Ronald C. Renaud, Jr.
|
| |
Member of the Board of Directors
|
| |
November 29, 2017
|
|
| *Pursuant to Power of Attorney | | |||
| *By: | | |
/s/ Timothy W. Trost
|
|
| | | |
Timothy W. Trost
|
|
1 Year Chimerix Chart |
1 Month Chimerix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions